Health Condition 1: null- Patients diagnosed with Diabetes Mellitus
Conditions
Interventions
Intervention1: Pre and Probiotic capsules: Each capsule contains Lactobacillus salivarius UBLS-22 â?? 5 billion cfu
Lactobacillus casei UBLC-42 -5 billion cfu
Lactobacillus plantarum UBLP-40-5 billion cfu
Bifidobacterium breve UBBBr-01-5 billion cfu
Lactobacillus acidophilus UBLA-34 -5 billion cfu
Bacillus coagulans Unique IS-2 - 5 billion cfu and
Fructo-Oligosaccharides-100 mg
Dosage : Each capsule taken two times per day for 90 days
Intervention2: probiotic capsule: probiotic capsule wit
Sponsors
Unique Biotech Limited
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Diabetes Mellitus and willing for the study.
Exclusion criteria
Exclusion criteria: • Critically ill patients. • Significant immunodeficiency. • Use of probiotics within 3 months before inclusion. • Participation in anyclinical study within the last 6 months. • Daily alcohol consumption > 30g. • Systemic antibiotics within 6 weeks before inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the probiotic mediated Glycemic control & improved quality of life.Timepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To analyse the effects of probiotics on health related quality of life in patients with diabetes mellitus. â?¢ To assess the patient compliance to the probiotic intake. â?¢ To determine the effect of probiotics on blood glucose markers such as Fasting blood sugar(FBS), Glycosylated hemoglobin(HbA1C) &Post prandial blood sugar(PPBS). Timepoint: NA | — |
Countries
India
Contacts
Public ContactDr Rajesh Venkataraman
S A C COLLEGE OF PHARMACY B.G.NAGARA
Outcome results
None listed